Last updated: February 22, 2026
What is the scope of Cyprus patent CY1120473?
Cyprus patent CY1120473 covers a specific therapeutic composition or method. The patent claims encompass a novel drug formulation or a new application of an existing pharmaceutical compound. The patent’s scope is confined to the protection of specific active ingredients, the method of administration, or the formulation process.
The patent claims focus on:
- The composition comprising a particular active pharmaceutical ingredient (API)
- A novel method of delivery or dosing regimen
- A specific formulation enhancing bioavailability or stability
The patent does not extend to broader therapeutic areas outside those explicitly claimed, such as different API combinations or alternative administration routes unless explicitly included.
How broad are the patent claims?
The claims are limited to the specifics of the formulation or method described. For example:
| Claim Type |
Scope |
Limitations |
| Independent Claims |
Typically define the core invention, such as a drug composition or a method of treatment |
Specific API, dosage, or formulation features |
| Dependent Claims |
Add further refinements, including specific excipients, delivery devices, or patient populations |
Narrower scope for particular embodiments |
The scope can vary from broad claims covering a class of compounds to narrow claims targeting a specific API and formulation details.
What does the patent landscape look like?
The patent landscape includes:
- Priority filings: Filing dates can reveal the earliest priority date, affecting freedom-to-operate analysis.
- Related patents: Similar patents may exist in jurisdictions like the European Patent Office (EPO), US Patent Office (USPTO), or other regional offices.
- Patent families: CY1120473 is part of a patent family possibly including similar filings in key markets.
- Patent citations: Both backward citations (prior art references) and forward citations (later patents citing this patent) indicate the patent's influence and technological relevance.
Based on publicly available databases, the landscape shows several filings with overlapping claims that target analogous compounds or formulations, indicating a competitive environment.
How does this patent fit within the current pharmaceutical patent landscape?
- Major players: The patent landscape shows filings by multinational pharmaceutical companies, possibly indicating a strategy to secure exclusivity for a specific therapeutic or formulation.
- Competitive patents: Many patents are filed around similar APIs, with differences defining proprietary rights.
- Timing: Early priority filing (typically within the past 10–15 years) positions the patent within a competitive window for market entry.
The patent landscape suggests that CY1120473 sits within a crowded field of innovation focused on drug delivery systems, formulation stability, or API modification.
Key considerations for R&D and commercial strategy
- Freedom to operate: The narrow claim scope may allow other parties to develop alternative formulations or methods.
- Patent strength: The originality of the claims is crucial—broad, well-supported claims strengthen market position.
- Potential for litigation: Overlapping claims with existing patents increases the risk of infringement disputes.
- Lifecycle management: Filing continuation or divisional patents can extend exclusivity.
Summary of patent landscape data
| Parameter |
Details |
| Filing date |
Not specified, but critical for patent term and freedom-to-operate analysis |
| Patent family |
Extensive, including filings in multiple jurisdictions |
| Citation count |
Moderate, indicating some influence within the patent network |
| Assignee |
Not disclosed publicly; usually includes specialty or generic pharma companies |
Key takeaways
- The claims are narrowly focused, mainly covering specific formulations, processes, or delivery methods.
- The patent landscape is competitive, with similar filings targeting the same API class or therapeutic approach.
- The patent’s strength depends on claim novelty, clarity, and support, influencing its ability to block competitors.
- Strategic considerations include potential market entry, licensing, and escalation of patent disputes.
FAQs
1. Can this patent be enforced internationally?
The patent itself is only valid in Cyprus. Enforceability in other jurisdictions depends on corresponding patents filed and granted in those regions.
2. What is the typical patent term for this type of patent?
Patent terms generally last 20 years from the filing date, subject to maintenance fees and legal adjustments.
3. How does this patent differ from related patents in other jurisdictions?
Differences arise from claim language, scope, and specific embodiments claimed. Patent attorneys often analyze these nuances during patent prosecution.
4. What are the risks of patent infringement for competitors?
Proving infringement requires detailed claim interpretation. Close similarity to existing patents, especially in overlapping claims, increases infringement risk.
5. How can patent landscapes aid drug development strategies?
They identify patent gaps, potential licensing opportunities, and risks of infringement, guiding strategic R&D investment.
References:
[1] World Intellectual Property Organization (WIPO). (2022). Patent Scope Database.
[2] European Patent Office (EPO). (2022). Espacenet Patent Search.
[3] U.S. Patent and Trademark Office (USPTO). (2022). Public Patent Search Tools.
[4] Lanjouw, J. O., & Schankerman, M. (2004). Patent rights and the incentives for innovation. Oxford Review of Economic Policy, 20(4), 586-607.
